Protease Inhibitors: General Research
- NNRTI Resistance Occurs More Often at Lower Levels of Adherence Than Does PI Resistance (July 14, 2004)
In The XV International AIDS Conference, from TheBodyPRO.com
- Confort Study Supports Switch From Protease Inhibitor to Nevirapine (July 14, 2004)
In The XV International AIDS Conference, from TheBodyPRO.com
- Tipranavir Reduces Concentrations of Other Protease Inhibitors (July 14, 2004)
In The XV International AIDS Conference, from TheBodyPRO.com
- Drug Development News: Gilead (May/June 2004)
A new prodrug technology targeting lymphocytes could all but revolutionize protease inhibitor therapy.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Changes to Labeling for Desyrel (Trazodone Hydrochloride) Tablets (PDF) (May 2004)
A "Dear Healthcare Professional" letter on potential interactions between this antidepressant and CYP3A4 inhibitors such as indinavir and ritonavir.
From U.S. Food and Drug Administration
- Protease Inhibitor Therapy: Boosted and Double-Boosted Options to the Fore (March 2004)
In The PRN Notebook
- Triple-PI Regimens for Rescue Treatment (February 10, 2004)
In The 11th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Dual-PI Regimen Preferred Over Single-PI Regimen After Initial PI Failure (February 9, 2004)
In The 11th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Clinical Efficacy of Antiretroviral Combination Therapy Based on Protease Inhibitors or Non-Nucleoside Analogue Reverse Transcriptase Inhibitors: Indirect Comparison of Controlled Trials (January 31, 2004)
Three-drug regimens containing a protease inhibitor are found to more effectively suppress HIV than three-drug regimens containing NNRTIs.
In British Medical Journal
- Endothelial Function in HIV-Infected Patients Receiving Protease Inhibitor Therapy: Does Immune Competence Affect Cardiovascular Risk? (November 2003)
Abstract of a study in the Quarterly Journal of Medicine.
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- Switching From PI to Nevirapine in Patients With Undetectable Viral Load Is Safe and Potent (September 15, 2003)
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from TheBodyPRO.com
- Association Between Protease Inhibitor Use and Increased Cardiovascular Risk in Patients Infected With Human Immunodeficiency Virus: A Systematic Review (September 12, 2003)
In Clinical Infectious Diseases
- Substitution of Nevirapine, Efavirenz, or Abacavir for Protease Inhibitors in Patients With Human Immunodeficiency Virus Infection (September 11, 2003)
In The New England Journal of Medicine
- Protease Inhibitors and Severe Adverse Events (July 14, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from TheBodyPRO.com
- Better Suppression, Adherence With Once-Daily FTC/ddI/Efavirenz Than Most PI-Based Regimens (July 14, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from TheBodyPRO.com
- Switch to Nevirapine From Protease Inhibitor Lowers Triglycerides and Maintains Viral Load Suppression (July 14, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from TheBodyPRO.com
- Older PIs Linked to Early Coronary Artery Disease (April 7, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
On TheBodyPRO.com
- Protease Inhibitors and Atherosclerosis (January/February 2003)
In TAGline, from Treatment Action Group
- Research From the 42nd ICAAC: Two PIs vs. Two PIs vs. Efavirenz (December 2002)
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- Immune Reconstitution Is Similar in Antiretroviral-Naive Subjects Following 1 Year of Therapy With a Triple NRTI-Based or Protease Inhibitor-Containing ARV Regimen (November 21, 2002)
In The 6th International Congress on Drug Therapy in HIV Infection, from TheBodyPRO.com
- 104 Weeks Outcome of Simplified Regimens in PI-Experienced Patients (November 19, 2002)
In The 6th International Congress on Drug Therapy in HIV Infection, from TheBodyPRO.com
|
Advertisement
|
Email
Glossary
